Poor engagement and adherence predict neoplasia in inflammatory bowel disease: a case‐control study

Abstract

Background Colorectal adenocarcinoma is an important and preventable complication of inflammatory bowel disease (IBD). A previous case series suggested mental health issues and poor engagement in care as novel risk factors. Aims To confirm the role of patient engagement in care in the development of neoplasia using a case‐control methodology. Methods Patients in a single referral centre from 2007 to 2017 with colorectal adenocarcinoma, high‐grade dysplasia or multifocal low‐grade dysplasia were included as neoplasia cases. Each case was assigned up to three matched controls (matched for age, gender, underlying disease, IBD type and phenotype and disease duration). Novel and known risk factors were compared between groups. Results Thirty‐two cases with 88 matched controls were included. Patients with neoplasia were more likely to have poor adherence to, or engagement with, care (odds ratio (OR) 4.79). They were also more likely to have chronic use of opioids (OR 3.86) and long‐term prednisolone (OR 2.97). Of note, no difference was found in measures of socioeconomic disadvantage, reflecting equitable access to healthcare in the public institution where the care was studied. As previously shown, patients with neoplasia had multiple markers of increased cumulative burden of inflammation, including more IBD‐related hospital admissions, elevated inflammatory markers and severe inflammation at colonoscopy. Conclusions This study confirms poor adherence or engagement with care as a new risk factor for colorectal adenocarcinoma in patients with IBD; identifying a vulnerable group whom clinicians should endeavour to engage in order to avoid this catastrophic complication.